PAVM (PAVmed) GF Score: 32/100 (As of Jun. 29, 2026) — 14% Above Median


PAVM PAVmed Inc PAVM
32 GF Score
Price $5.36
GF Value $1.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PAVmed GF Score?

PAVmed PAVM +10.97% 32 GF Score is 32 as of Jun. 29, 2026, which is 14% above its 10-year median of 28.00. GuruFocus rates PAVM with a GF Score™ of 32/100 and a GF Value™ of $1.27 (Significantly Overvalued). The stock has 6 warning signs investors should review.

PAVmed has the GF Score of 32, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 1/10
5. Momentum Rank : 3/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes PAVmed might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

PAVmed  (NAS:PAVM) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

PAVmed GF Score Related Terms

PAVM vs BDMD, TELA, NSPR: GF Score Comparison

For the Medical Devices subindustry, PAVmed's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PAVmed GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PAVmed's GF Score distribution charts can be found below:

* The bar in red indicates where PAVmed's GF Score falls into.


PAVM
32GF Score
PAVmed Inc PAVM
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 32 mean?
PAVmed (PAVM) has a GF Score of 32 as of Jun. 29, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on PAVmed and its competitors. This is 14% above median its historical median of 28.00. Over the past decade, PAVmed's GF Score has ranged from 16.00 to 48.00.
Is PAVmed's GF Score too high?
PAVmed's current GF Score of 32 is 14% above median its 10-year median of 28.00. Over the past 10 years, this metric has ranged from a low of 16.00 to a high of 48.00. Overall, PAVmed has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PAVmed's GF Score compare to BDMD and TELA?
PAVmed's GF Score of 32 can be compared against companies in the Medical Devices & Instruments industry. Historically, PAVmed's own GF Score has ranged from 16.00 to 48.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on PAVmed and its competitors. PAVmed's current GF Score is 32, which is 14% above median its own 10-year median of 28.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAVmed stock overvalued right now?
Based on GuruFocus' analysis, PAVmed (PAVM) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.27, compared to a current price of $5.36 — trading 322% above its estimated fair value. The current GF Score is 32, which is 14% above median its 10-year median of 28.00. PAVmed's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For PAVmed (PAVM), the current GF Score is 32 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PAVmed (PAVM) Overvalued in 2026?

Based on GuruFocus' analysis, PAVmed stock appears to be overvalued. The current stock price of $5.36 is trading 322% above its estimated GF Value™ of $1.27. GuruFocus considers PAVmed to be Significantly Overvalued.

Key valuation signals for PAVM:

  • GF Score: 32 (14% above median its 10-year median of 28.00)
  • GF Value™: $1.27 vs. price of $5.36 (322% above fair value)
  • GF Score™: 32/100 with 6 warning signs

No single metric tells the full story. See the PAVM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PAVmed Business Description

Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
32GF Score

Get the complete analysis for PAVM

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.36
Price
$1.27
GF Value